Rezolute, Inc. financial data

Symbol
RZLT on Nasdaq
Industry
Pharmaceutical Preparations
Location
275 Shoreline Drive, Suite 500, Redwood City, CA
State of incorporation
NV
Fiscal year end
June 30
Former names
AntriaBio, Inc. (to 12/7/2017), FITS MY STYLE INC (to 1/11/2013)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.28K % -35.8%
Debt-to-equity 12.3 % +83.6%
Return On Equity -69.9 % -51%
Return On Assets -62.2 % -43.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.4M shares +50.3%
Common Stock, Shares, Outstanding 55.4M shares +50.4%
Entity Public Float 33.3M USD -47.7%
Common Stock, Value, Issued 55K USD +48.6%
Weighted Average Number of Shares Outstanding, Basic 69.7M shares +35.6%
Weighted Average Number of Shares Outstanding, Diluted 69.7M shares +35.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 56.3M USD +16.5%
General and Administrative Expense 15.2M USD +13.5%
Operating Income (Loss) -71.5M USD -15.8%
Nonoperating Income (Expense) 2.14M USD -59%
Net Income (Loss) Attributable to Parent -69.4M USD -22.8%
Earnings Per Share, Basic -1.27 USD/shares -15.5%
Earnings Per Share, Diluted -1.27 USD/shares -15.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.5M USD +30%
Marketable Securities, Current 97.8M USD +7.86%
Assets, Current 110M USD +7.34%
Property, Plant and Equipment, Net 95K USD -26.4%
Operating Lease, Right-of-Use Asset 1.75M USD -9.42%
Assets 123M USD +9.22%
Accounts Payable, Current 2.18M USD -10.5%
Employee-related Liabilities, Current 2.65M USD +57.8%
Liabilities, Current 7.99M USD +11.1%
Operating Lease, Liability, Noncurrent 1.5M USD -17.4%
Liabilities 9.97M USD +5.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 289K USD
Retained Earnings (Accumulated Deficit) -345M USD -25.2%
Stockholders' Equity Attributable to Parent 113M USD +9.54%
Liabilities and Equity 123M USD +9.22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16M USD -51.3%
Net Cash Provided by (Used in) Financing Activities 5.5M USD
Net Cash Provided by (Used in) Investing Activities -49.4M USD -1996%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 55.4M shares +50.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -59.9M USD -651%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.5M USD +30%
Deferred Tax Assets, Valuation Allowance 69.8M USD +17.9%
Deferred Tax Assets, Gross 70.3M USD +17.6%
Operating Lease, Liability 2.08M USD -10.9%
Payments to Acquire Property, Plant, and Equipment 70K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -68.7M USD -21.1%
Lessee, Operating Lease, Liability, to be Paid 2.31M USD -13.6%
Property, Plant and Equipment, Gross 210K USD 0%
Operating Lease, Liability, Current 584K USD +11.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 750K USD +16.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 770K USD +22.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 225K USD -32.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 750K USD +16.1%
Deferred Tax Assets, Operating Loss Carryforwards 38.9M USD -3.94%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 400K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 666K USD
Operating Lease, Payments 184K USD +7.6%
Additional Paid in Capital 458M USD +20.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 526K USD -8.52%
Share-based Payment Arrangement, Expense 6.91M USD -4.52%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%